<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="2" ids="50249">Anticoagulants</z:chebi> used in daily practice include low molecular weight <z:chebi fb="0" ids="24505">heparins</z:chebi> (LMWHs) and <z:chebi fb="6" ids="28384">vitamin K</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>LMWHs are easy to use by means of adjusted subcutaneous injection, weight-adjusted in case of therapeutic indications </plain></SENT>
<SENT sid="2" pm="."><plain>LMWHs are cleared principally by the renal route and are contra-indicated in case of <z:hpo ids='HP_0000083'>renal insufficiency</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The LMWHs are indicated in the prevention and treatment of venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>They can be safely administered in pregnancy and during breast-feeding </plain></SENT>
<SENT sid="5" pm="."><plain>Oral <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy is the treatment of choice for long term management </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="6" ids="28384">Vitamin K</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi> are contra-indicated in pregnancy, especially between the 6th and the 12th week of gestation (risk of <z:e sem="disease" ids="C0013949" disease_type="Disease or Syndrome" abbrv="">embryopathy</z:e>); they can be given during breast-feeding subject to some precaution </plain></SENT>
<SENT sid="7" pm="."><plain>Main indications for <z:chebi fb="6" ids="28384">vitamin K</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi> are long term treatment of venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>, prevention of both arterial and venous thrombo-embolic events associated with the <z:hpo ids='HP_0003613'>antiphospholipid--antibody</z:hpo> syndrome, prevention of <z:mpath ids='MPATH_118'>systemic embolism</z:mpath> associated with heart valves and, <z:e sem="disease" ids="C0264765" disease_type="Disease or Syndrome" abbrv="">rheumatic mitral valve disease</z:e> and, <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> and, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
</text></document>